School introduces new Master of Science program in Artificial Intelligence and Computational Drug Discovery and Development

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.
Source: UCSF School of Pharmacy News - Category: Universities & Medical Training Source Type: news